+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pruritus (Dermatology) - Drugs In Development, 2021

  • ID: 5359595
  • Drug Pipelines
  • June 2021
  • Region: Global
  • 221 pages
  • Global Markets Direct

FEATURED COMPANIES

  • 9 Meters Biopharma Inc
  • Albireo Pharma Inc
  • AntalGenics SL
  • Asana BioSciences LLC
  • BELLUS Health Inc
  • Biomimetix JV LLC
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

The publisher's latest Pharmaceutical and Healthcare disease pipeline guide Pruritus (Dermatology) - Drugs In Development, 2021, provides an overview of the Pruritus (Dermatology) pipeline landscape.

Pruritus, or itch, is defined as an unpleasant sensation that provokes the desire to scratch. Pruritus is caused by cancer, cancer treatments, infection, dry skin and reaction to a drug. Symptoms include redness, bumps, spots or blisters, dry, cracked skin and leathery or scaly texture to the skin. Risk factors include heat, allergic, asthma, hay fever, hives and eczema. Treatment includes corticosteroids, antihistamines and antidepressants.

Report Highlights

The publisher's Pharmaceutical and Healthcare latest pipeline guide Pruritus (Dermatology) - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Pruritus (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Pruritus (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Pruritus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 2, 5, 13, 9, 15, 2 and 2 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 3 molecules, respectively.

Pruritus (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Pruritus (Dermatology).
  • The pipeline guide reviews pipeline therapeutics for Pruritus (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Pruritus (Dermatology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Pruritus (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Pruritus (Dermatology)
Reasons to Buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Pruritus (Dermatology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Pruritus (Dermatology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 9 Meters Biopharma Inc
  • Albireo Pharma Inc
  • AntalGenics SL
  • Asana BioSciences LLC
  • BELLUS Health Inc
  • Biomimetix JV LLC
  • MORE
  • Introduction
  • Pruritus - Overview
  • Pruritus - Therapeutics Development
  • Pruritus - Therapeutics Assessment
  • Pruritus - Companies Involved in Therapeutics Development
  • Pruritus - Drug Profiles
Pruritus - Dormant Projects

Pruritus - Discontinued Products
  • Pruritus - Product Development Milestones
  • Appendix
List of Tables
  • Number of Products under Development for Pruritus, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Products under Development by Companies, 2021
  • Products under Development by Universities/Institutes, 2021
  • Number of Products by Stage and Target, 2021
  • Number of Products by Stage and Mechanism of Action, 2021
  • Number of Products by Stage and Route of Administration, 2021
  • Number of Products by Stage and Molecule Type, 2021
  • Pruritus - Pipeline by 9 Meters Biopharma Inc, 2021
  • Pruritus - Pipeline by Akaal Pharma Pty Ltd, 2021
  • Pruritus - Pipeline by Albireo Pharma Inc, 2021
  • Pruritus - Pipeline by Amgen Inc, 2021
  • Pruritus - Pipeline by AntalGenics SL, 2021
  • Pruritus - Pipeline by AOBiome LLC, 2021
  • Pruritus - Pipeline by Asana BioSciences LLC, 2021
  • Pruritus - Pipeline by Avior Bio Inc, 2021
  • Pruritus - Pipeline by BELLUS Health Inc, 2021
  • Pruritus - Pipeline by BioArdis LLC, 2021
  • Pruritus - Pipeline by Biomimetix JV LLC, 2021
  • Pruritus - Pipeline by Cara Therapeutics Inc, 2021
  • Pruritus - Pipeline by Clexio Biosciences Ltd, 2021
  • Pruritus - Pipeline by DermaXon LLC, 2021
  • Pruritus - Pipeline by DongKoo Bio & Pharma Co Ltd, 2021
  • Pruritus - Pipeline by ELORAC Inc, 2021
  • Pruritus - Pipeline by Escient Pharmaceuticals Inc, 2021
  • Pruritus - Pipeline by Evommune Inc, 2021
  • Pruritus - Pipeline by GlaxoSmithKline Plc, 2021
  • Pruritus - Pipeline by Jiangsu Hengrui Medicine Co Ltd, 2021
  • Pruritus - Pipeline by Kiniksa Pharmaceuticals Ltd, 2021
  • Pruritus - Pipeline by Kissei Pharmaceutical Co Ltd, 2021
  • Pruritus - Pipeline by Kolmar Pharma Co Ltd, 2021
  • Pruritus - Dormant Projects, 2021
  • Pruritus - Discontinued Products, 2021
List of Figures
  • Number of Products under Development for Pruritus, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products by Top 10 Targets, 2021
  • Number of Products by Stage and Top 10 Targets, 2021
  • Number of Products by Top 10 Mechanism of Actions, 2021
  • Number of Products by Stage and Top 10 Mechanism of Actions, 2021
  • Number of Products by Top 10 Routes of Administration, 2021
  • Number of Products by Stage and Top 10 Routes of Administration, 2021
  • Number of Products by Molecule Types, 2021
  • Number of Products by Stage and Molecule Types, 2021
Note: Product cover images may vary from those shown
  • 9 Meters Biopharma Inc
  • Akaal Pharma Pty Ltd
  • Albireo Pharma Inc
  • Amgen Inc
  • AntalGenics SL
  • AOBiome LLC
  • Asana BioSciences LLC
  • Avior Bio Inc
  • BELLUS Health Inc
  • BioArdis LLC
  • Biomimetix JV LLC
  • Cara Therapeutics Inc
  • Clexio Biosciences Ltd
  • DermaXon LLC
  • DongKoo Bio & Pharma Co Ltd
  • ELORAC Inc
  • Escient Pharmaceuticals Inc
  • Evommune Inc
  • GlaxoSmithKline Plc
Note: Product cover images may vary from those shown
Adroll
adroll